Govt steps up inspections at pharma units to ensure quality

Government authorities have conducted risk-based inspections at over 500 pharmaceutical manufacturing units since 2022 to enhance the quality of locally produced medicines and prevent the sale of spurious drugs. Over 400 actions have been taken against units failing to meet quality standards, and inspections are expected to continue.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ADHx6jV
via IFTTT